ESOT gratefully acknowledges the support of our Corporate Partners, Congress Supporters and Exhibitors
Abbott | Advances and More | Atara Biotherapeutics | Biotest | Bridge to Life | China Organ Harvest Research Center | CSL Behring | Dr. Franz Köhler Chemie | Donation & Transplantation Institute | E3 Cortex | EBERS Medical Technology | Eurofins | Fresenius Medical Care | Glycorex Transplantation | Hansa Biopharma | IGL | Immudex | Mallinckrodt | Natera | Neovii | One Lambda | OrganOx | Organ Assist | Organ Recovery Systems | QUOD | SALF | Sequana Medical | The Transplantation Society | TransMedics | ViroGates | Wiley | Wisepress.com
At Abbott, we’re committed to helping you live your best possible life through the power of health.
Advances and More is a technology company focusing on digital innovation in the medical field. Our digital solutions offer end-users a wealth of specialized educational material, information and media in a variety of medical disciplines and specialties. Transplant Tube, our latest platform, aims to connect innovation in transplantation across the globe.
Astellas is a pharmaceutical company that is committed to turning innovative science into medical solutions that bring value and hope to patients worldwide. Keeping our focus on addressing unmet medical needs and conducting our business with openness, integrity and a collaborative approach enables us to improve the health of people around the world.
Atara Biotherapeutics, Inc. (@Atarabio) is a leading off-the-shelf, allogeneic T-cell immunotherapy company developing novel treatments for patients with cancer, autoimmune and viral diseases. Atara’s most advanced T-cell immunotherapy, tab-cel®, is in Phase 3 development for patients with Epstein-Barr virus associated post-transplant lymphoproliferative disorder, as well as other EBV-associated hematological malignancies and solid tumors, including nasopharyngeal carcinoma.
Biotest AG is a provider of plasma proteins and biological drugs. With a value added chain that extends from pre-clinical and clinical development to worldwide sales, Biotest has specialised in the areas of clinical immunology, haematology and intensive medicine. Biotest develops and markets immunoglobulins, coagulation factors and albumin based on human blood plasma.
Bridge to Life moves in to machine perfusion of livers and kidneys. Known as the exclusive distributor of Belzer UW cold storage and Belzer MPS UW machine perfusion solutions, BTL is pleased to announce the launch of our new VitaSmart Duo perfusion device. See our ‘revolutionary’, cost effective VitaSmart Duo pump on the BTL stand.
Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused Healthcare Group, with over 80 years of experience in the pharmaceutical industry, present in 26 countries. Chiesi researches develops and markets innovative drugs in the respiratory therapeutics, specialist medicine and rare disease areas. Its R&D organisation is headquartered in Parma (Italy), and integrated with 6 other key R&D groups in France, the USA, the UK, Sweden and Denmark to advance Chiesi’s pre-clinical, clinical and registration programmes. Chiesi employs nearly 5,000 people. Chiesi entered in the solid organ transplant arena with Envarsus®, a prolonged-release tacrolimus formulation with a distinctive PK profile.
China Organ Harvest Research Center conducts and presents authoritative research on organ transplant abuse in China, including the killing of prisoners of conscience for organs. We look forward to collaborating with other researchers and medical professionals to help end these crimes and uphold ethics standards in the international transplant community.
CSL Behring is a global biotherapeutics leader driven by our promise to save lives. We meet patients’ needs using the latest technologies to develop and deliver innovative biotherapies that are used to treat serious and rare conditions such as coagulation disorders, primary immune deficiencies, hereditary angioedema and inherited respiratory disease.
Dr. Franz Köhler Chemie GmbH is an independent, family owned company with representations world-wide. Since 1959 we are a reliable partner for transplant and cardiac surgery centers and the ICU. Our portfolio includes anesthetics, medical devices, electrolytes, contrast-media, antidotes, organ-protective and cardioplegic-solutions. The company is world-wide known for its Custodiol®.
Donation & Transplantation Institute (DTI) is an NGO with the commitment to raise organ donation and to improve society’s quality of life.
Transplant Procurement Management (TPM®) is its educational program that has trained over 15.000 participants globally, adapting the courses contents to the specific needs of the diverse countries’ situation.
Specialist for over 35 years in the design and manufacture of custom or standard packages, E3 Cortex adapts to customers’ specific needs, taking constant care to upgrade its products’ quality, as well as in the areas of hazardous, fragile or temperature-sensitive products.
EBERS is a manufacturer of medical devices for ex vivo normothermic preservation and viability assessment of solid organs with applications in renal and hepatic transplantation. In addition, EBERS is a worldwide supplier of laboratory equipment in the fields of tissue engineering and regenerative medicine.
Eurofins is a key emerging player in specialty clinical diagnostics testing globally. Eurofins’ industry leading Transplant Diagnostics offering, includes VRL, the largest pre-transplant laboratory and Viracor, the largest specialty US post-transplant clinical laboratory. Eurofins’ transplant footprint has been recently broadened with the acquisition of Transplant Genomics and its blood gene expression test, TruGraf®.
Therapeutic Apheresis of Fresenius Medical Care is dedicated to provide extracorporeal therapies with (semi-)selective adsorber and filter. Thereby harmful pathogens causing various autoimmune diseases or metabolic disorders can be effectively depleted from the blood. These alternative treatment methods can be beneficial in acute or chronic disease conditions.
Glycosorb®-ABO effectively reduce anti-A/B antibodies in human plasma through A/B antigen specific binding. Glycosorb®-ABO has been used clinically since 2001. To date, more than 180 transplant centers on four continents have treated more than 4,000 adult and pediatric patients. Reported short- and long-term results are excellent even at 10-year follow-up.
Hansa Biopharma is a biopharmaceutical company developing novel immunomodulatory enzymes for organ transplantation and acute autoimmune diseases. The Company’s lead product, imlifidase, is a proprietary, antibody-degrading enzyme in late-stage clinical development for kidney transplant patients, with the potential for further development in other solid organ transplantation and acute autoimmune indications. Hansa also has a strong pipeline of preclinical projects, including NiceR, through which the Company is developing novel immunoglobulin-cleaving enzymes for repeat dosing in relapsing autoimmune diseases and oncology.
IGL, consists of a network of subsidiaries located worldwide. This means we are never far from our customers and so can help them to meet their local challenges. We design, manufacture, and market proprietary and generic products for organ preservation devices. Our products are essential for the success of organ transplantations.
Based in Copenhagen, Denmark, Immudex manufactures MHC Dextramers for the detection of antigen-specific T cells in life science research, in vitro diagnostics, and the development of immunotherapeutics and vaccines. Under an agreement with the US Cancer Immunotherapy Consortium (CIC) and the European Cancer Immunotherapy Consortium (CIMT), Immudex also provides MHC Multimer and Elispot proficiency panel services worldwide.
Mallinckrodt is a global business that develops, manufactures, markets and distributes specialty pharmaceutical products and therapies. Mallinckrodt is the only provider of integrated systems for the delivery of Extracorporeal Photopheresis (ECP).
Natera is a global leader in cell-free DNA testing. The mission of the company is to transform the management of diseases worldwide. Nateraoperates an ISO 13485-certified and CAP-accredited laboratory certified under the Clinical Laboratory Improvement Amendments (CLIA) in San Carlos, Calif. It offers a host of proprietary genetic testing services to inform physicians who care for pregnant women, researchers in cancer including biopharmaceutical companies, genetic laboratories through its cloud-based software platform – and now transplant physicians monitoring patients for allograft rejection.
Neovii is an independent, global biopharmaceutical company with a patient-focused mission to develop and bring to market novel life-transforming therapies to improve the outcomes in transplantation medicine, hemato-oncological and immune disorders. Neovii’s global headquarters are located in Rapperswil, Switzerland and has presence in over 50 countries worldwide.
Novartis provides innovative healthcare solutions that address the evolving needs of patients and societies. Headquartered in Basel, Switzerland, Novartis offers a diversified portfolio to best meet these needs: innovative medicines, eye care and cost-saving generic pharmaceuticals. Novartis is the only global company with leading positions in these areas. In 2016, the Group achieved net sales of USD 48.5 billion, while R&D throughout the Group amounted to approximately USD 9.0 billion (USD 8.4 billion excluding impairment and amortization charges). Novartis Group companies employ approximately 118,000 full-time-equivalent associates. Novartis products are sold in approximately 155 countries around the world.
One Lambda, Inc., is a global leader in transplant diagnostics with a commitment to improve the lives of patients worldwide by driving innovation and delivering quality products. Our comprehensive product portfolio includes a broad range of industry-leading antibody detection and monitoring solutions, HLA Typing products, laboratory instrumentation and software, and industry-leading customer support.
OrganOx is a medical device company with a mission to save lives by making every donated organ count. Our first product, the CE marked metra®, enables the perfusion of donor livers for up to 24 hours at normal body temperature, allowing assessment of organ performance prior to transplant.
Organ Assist is a knowledge-based company ensuring better-quality organs and relieving time pressure on the organ transplantation procedure. Organ Assist has been fully dedicated to expanding the quality and availability of donor organs. Our unique portfolio enables oxygenated machine perfusion at all pathway stages; during preconditioning, preservation and reconditioning.
Organ Recovery Systems, the global market-leading provider of organ preservation products and services, supports 286 transplant programs in 39 countries with the LifePort® Kidney Transporter and preservation solutions: SPS-1® (UW Solution) and KPS-1® (UW machine perfusion solution). The LifePort Liver Transporter is undergoing regulatory review in the US and EU.
Quality in Organ Donation (QUOD) is a national consortium formed of clinicians and scientists from intensive care and transplant units across the United Kingdom, working together with dedicated operational staff from NHS Blood and Transplant (NHSBT) and its directorate Organ Donation & Transplantation to facilitate research to increase the number of organs available for transplantation.
Headquartered in Basel, Switzerland, Roche is a leader in research-focused healthcare with combined strengths in pharmaceuticals and diagnostics. Roche is the world’s largest biotech company with truly differentiated medicines in oncology, virology, inflammation, metabolism and CNS. Roche’s transplant treatments are designed to support the long-term survival of transplanted organs.
SALF (S.A.L.F. S.p.A. Laboratorio Farmacologico) was founded in 1921 and it specializes in the production of injectable products for both national and international market. SALF supplies hospitals, nursing homes, and clinics. All of our products are Made in Italy.
At Sandoz, we discover new ways to improve and extend people’s lives. We pioneer novel approaches to help people around the world access high-quality medicine. To achieve this, we pursue an integrated access strategy that focuses our work on improving access to medicines, access to medical information and access to medical capacity building, which includes efforts to provide and support appropriate training for healthcare professionals. In 2015, our products reached an estimated 520 million patients and our aspiration is to reach 1 billion people.
Sequana Medical produces the alfapump® an implantable, programmable, transcutaneously-charged, battery-powered pump for the management of RA due to liver cirrhosis or malignant ascites with a life expectancy of 6 months or less. It is one of the first real alternatives to LVP. By moving ascites to the bladder, it prevents fluid build-up, improving patient QOL and nutrition, and potentially reducing hospital visits and healthcare costs. DirectLink Technology allows clinicians to receive pump performance information and more effectively manage patients treated. CE 616535.
Takeda is a global, values-based, R&D-driven biopharmaceutical leader headquartered in Japan, committed to bringing Better Health and a Brighter Future to patients by translating science into highly-innovative medicines. Takeda focuses its R&D efforts on four therapeutic areas: Oncology, Gastroenterology (GI), Neuroscience and Rare Diseases. We also make targeted R&D investments in Plasma-Derived Therapies and Vaccines.
Established in 1966, TTS serves as the principle International forum for the advancement of both basic and clinical transplantation science throughout the world. The Transplantation Society is a Non-Governmental Organization (NGO) which is composed of over 6500 professionals including but not limited to, physicians, surgeons and scientists in over 105 countries.
TransMedics was founded to address the growing need for healthier organs for transplantation. We are focused on transforming the standard of care – increasing organ utilization, improving patient outcomes, and reducing transplant costs. The OCS is the first and only multi-organ platform to leverage proprietary core technologies across multiple organs.
Founded in 2004 as a socially-conscious medical software company, Transplant Connect is the world’s leading provider of human biologics (organ, tissue, eye, placenta and other) donation and transplantation software. Our award-winning, secure cloud-based iTransplant℠ Donation and Transplantation Platform enables nearly 75% of all deceased organ donation in the U.S. and is used by more than 12,500 medical professionals at over 100 donation and transplantation agencies all over the world – from across the United States to Canada, India and Australia.
ViroGates´ product line called suPARnostic® is a commercially available test, that can measure the protein called suPAR in the blood. More than 550 publications have followed, substantiating suPAR as one of the most promising prognostic biomarker tools for various areas of healthcare; eg. to predict the risk of mortality within organ transplantation.
Wiley is proud to partner with ESOT to publish Transplant International. Wiley is a global provider of knowledge and knowledge-enabled services in research, professional practice and education. Developing digital education, learning, assessment and certification, partnering with societies and communicating research discoveries.
Wisepress.com, Europe’s leading conference bookseller, has a complete range of books and journals relevant to the themes of the meeting. Books can be purchased at the stand or, if you would rather not carry them, posted to you – Wisepress will deliver worldwide. In addition to attending 200 conferences per year, Wisepress has a comprehensive medical and scientific bookshop online with great offers.
02 SEP 2019
END OF REGULAR
06 SEP 2019
15 SEP 2019
START OF THE
18 SEP 2019
END OF THE